RBC Capital Brian Abrahams looks at a possible LBO for Celgene (NASDAQ: CELG) given shares trade at a forward P/E ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE